CardiNor AS

medical devices

About

CardiNor AS is a Norwegian diagnostic company founded in 2015 to handle the assay development and commercialization of the cardiac biomarker secretoneurin (SN). SN addresses a medical unmet need by providing prognostic insight and risk stratification of patients with life threatening arrhythmias to aid in patient selection for ICD treatment (implantable cardioverter-defibrillator), and other cardiovascular diseases (CVD). The company has established an extensive network of Key Opinion Leaders (KOLs) in the field that has provided CardiNor with access to large international, renowned clinical cohorts for the documentation and validation of the SN ELISA assay. Supported by the Norwegian Research Council, CardiNor is on track with its bead-based SN assay for high throughput testing platforms. CardiNor is located in Oslo with an R&D department in Bodø, in northern Norway.

Technologies

Outlook Microsoft Office 365 Google Font API Mobile Friendly Apache Varnish WordPress.org Android

Keywords

immunoassays research development innovation secretoneurin medical diagnostics medical equipment manufacturing heart failure diagnostics clinical cohorts biomarker for functional heart disease prognostic biomarker biomarker for sudden cardiac death clinical validation biomarker for septic shock prognostic indicator diagnostic kit diagnostic development high throughput testing secretoneurin elisa clinical research b2b biomarker panel cardiac biomarkers medical and diagnostic laboratories healthcare personalized medicine biomarker for cardiac prognosis cardiology cardiomyocyte calcium handling elisa assay cardiovascular disease

Location

21 Gaustadalleen, Oslo, Oslo, Norway, 0349

Related Companies

Companies in the same industry